Abeona Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Vishwas Seshadri, with a market cap of $292.1M.
Common questions about Abeona Therapeutics Inc.
Abeona Therapeutics Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $5.6M.
Abeona Therapeutics Inc. has approximately 84 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.